Delivery Order SPE2DX22D0049-SPE2D825FB0CA
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $8,307.41 to AmerisourceBergen Drug Corp on July 21, 2025, for pharmaceutical and medical supply delivery. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 22, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp on July 29, 2025, with ultimate completion also set for that date. This firm fixed price delivery order represents a non-competitive award under an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The awardee is a major pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain awarded a $561,251.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for completion by July 29, 2025. This non-competitive, non-set-aside delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is being performed at the awardee's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,264.90 to AmerisourceBergen Drug Corp on August 5, 2025, with a completion deadline of August 6, 2025. This firm fixed-price delivery order, classified as a child contract under the company's larger indefinite delivery vehicle with DLA Troop Support Medical, represents a competitively awarded, non-set-aside transaction. The award was made to AmerisourceBergen's Corporate Office division, headquartered...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $17,367.28 to AmerisourceBergen Drug Corp on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract issued to the prime contractor's Corporate Office division, located in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $15,465.37 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order, which was competitively awarded with no set-aside designation, represents a child order issued under a larger contract vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,594.24 to AmerisourceBergen Drug Corp on August 19, 2025, with completion anticipated by August 20, 2025. This firm fixed-price delivery order, issued under a competitive procurement with no set-aside designation, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $31,850 to AmerisourceBergen Drug Corp on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed price contract, issued without set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which is valued at $999,999,999 and extends through December 2026. The prime contractor...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,963.84 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, issued under contract number 4569048102, represents a non-set-aside competitive award to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $16,586.58 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, with completion expected by August 12, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreements. The award is directed to the company's corporate office located in Conshohocken, Pennsylvania, where the company maintains its primary operations as...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D825FB0CADelivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $11,549.78 to AmerisourceBergen Drug Corp on August 18, 2025, with performance completion targeted for August 19, 2025. This non-competitive delivery order was issued from the Corporate Office division of AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, where the work is also being performed. The contract represents a single delivery order under a larger indefinite delivery vehicle supporting federal medical procurement requirements. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen supplies a comprehensive range of medical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and federal healthcare systems. The company's role as a critical supplier demonstrates its established capability to meet federal medical supply needs through its extensive portfolio of pharmaceutical distribution services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.5k | 8/18/25 |